ORMP vs MNOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 04, 2026

ORMP

32.1
AI Score
VS
MNOV Wins

MNOV

38.7
AI Score

Investment Advisor Scores

ORMP

32score
Recommendation
SELL

MNOV

39score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ORMP MNOV Winner
Revenue 2.00M 645,423 ORMP
Net Income -7.64M -4.90M MNOV
Net Margin -382.1% -759.3% ORMP
Operating Income -4.50M -5.38M ORMP
ROE -5.4% -13.1% ORMP
ROA -5.2% -12.1% ORMP
Total Assets 147.54M 40.43M ORMP
Current Ratio 23.94 8.75 ORMP
Free Cash Flow -3.52M -5.40M ORMP

Relative Price Performance (Last 90 Days)

ORMP 1M: -11.4% · 3M: -1.8% MNOV 1M: +24.5% · 3M: +23.6%

Current Technical Phase

ORMP

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 39

RSI (14): 38.5 · Price: $4.49

MNOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 43.5 · Price: $1.78

Fundamentals Snapshot

Metric ORMP MNOV
Market Cap — —
Forward P/E 0.0 -3.5
Trailing P/E 1.1 —
Revenue (TTM) — —
Revenue Growth -1.0% 2.4%
Gross Margin — 0.4%
Operating Margin 0.0% -5.5%
EPS 4.13 -0.21
Dividend Yield 0.00% —

Frequently Asked Questions

Based on our detailed analysis, MNOV is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.